The Inspire ANTI SNORING Implant is a medical device that’s implanted into the body for the treating snoring and obstructive sleep apnea (OSA) syndrome.
Obstructive Sleep Apnea Syndrome
Obstructive anti snoring syndrome is really a disease caused by relapsing episodes of sleep apnea. That is a condition where breathing stops for a lot more than 10 seconds, where oxygen saturation in the blood is reduced by a lot more than 4%.
OSA syndrome occurs while asleep, when the muscles of upper airways relax, causing the obstruction of the respiratory system. This leads to deterioration of blood oxygenation and provokes short unconscious wake-up episodes through the entire night. ufabet An unhealthy pattern of sleep places pressure on the body, causing increased blood pressure and development of severe diseases. The diseases caused by OSA could be physical, such as for example hypertension, myocardium infarction and stroke. They could also be mental, including depression, chronic fatigue syndrome, loss of memory and concentration.
Before any treatment, a sleep study or perhaps a polysomnography is needed. The polysomnography calculates the apnea index, which is the frequency of apnea episodes during 1 hour of sleep and determines the severe nature of the condition. The apnea index is considered significant if you can find more than 20 apnea episodes per hour, whatever the presence or absence of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy is not for everyone as many folks think it is uncomfortable to sleep with the mask on the face and the device itself can be loud, especially since it commonly sits near the head. Only 25% of patients can use CPAP-therapy for a long period of time.
Therefore, recently Inspire Medical Systems Inc. has come up with a very effective solution with the Inspire Sleep Apnea Implant.
How The Inspire ANTI SNORING Implant Works
The Inspire ANTI SNORING Implant is really a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately a decade.
The main unit of the device is placed beneath the skin, on the front right side of the chest and it monitors the phase of breathing. Another electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens top of the airways and allows the tongue to stick out, and helps maintain the airways open while asleep.
In addition to the two electrodes, this product also contains a handy small remote switch, which actually turns on the device before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating during the active phase of your day, whenever a person needs physiological narrowing of the larynx and tongue movements for these processes.
The patient may feel light involuntary contractions of the larynx, or tongue movements during initial use of the device. These movements do not cause pain, instead only a minor discomfort. These unpleasant effects disappear following the first few uses of the device.
Generally, the implant ought to be checked one or two 2 times per year. However, based on the situation, an Inspire therapy-trained doctor may consult patients pretty much often.
The Inspire ANTI SNORING Implant is only suitable for:
Patients who are more than 22 years old.
Patients who have been diagnosed with moderate or severe obstructive anti snoring syndrome.
Patients having an apnea index in the number of 20 to 65.
Patients who are not comfortable with using CPAP therapy or did not have the desired effect.
Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
An individual with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire Sleep Apnea Implant may potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive anti snoring syndrome. A report by Dr. Ryan J. et al. shows that after implantation of the Inspire ANTI SNORING Implant, snoring is greatly decreased. A percentage of “no” or “soft” snoring changed from 22% at beginning of the treatment to 88% at 12 months and 91% at 24 months after the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the analysis reported a nightly usage of this therapy for five years. Therefore, it really is evident that method is impressive and easy to use!